April 2026
The global bunion surgery market size was estimated at USD 489.5 million in 2025 and is predicted to increase from USD 517.6 million in 2026 to approximately USD 855.36 million by 2035, expanding at a CAGR of 5.74% from 2026 to 2035.
Globally rising cases of the geriatric population, sports injuries, and other associated incidences, such as arthritis. For these cases, the healthcare professionals are fostering rigorous solutions, like minimally invasive surgery, and advanced AI-powered approaches.
Firstly, the bunion surgery market covers a procedure that corrects a hallux valgus deformity, i.e. a bony bump at the base of the big toe. This significant procedure and overall market expansion are driven by a rise in the geriatric population, accelerating bunion cases, which are associated with footwear/lifestyle/sports, and ongoing breakthroughs in implants and minimally invasive techniques (MIS). However, healthcare professionals are leveraging 3D surgical planning and correction, such as Lapiplasty, which considers the bunion as a 3D deformity by correcting the unstable joint at the base of the big toe instead of just removing the visible bump.
The respective market has been bolstering the adoption of AI algorithms through the strengthening of pre-operative planning software, patient-matched surgical guides, and robotic assistance, which ensures higher precision and potentially rapid recovery times. Recently, Johnson & Johnson MedTech introduced the VIRTUGUIDE system. This patient-matched solution utilises AI software for the selection of the most appropriate, patient-specific Virtual Alignment and Correction (VAC) Guide for a Lapidus procedure (a type of bunion surgery).
Exploration of Tailored Surgical Planning & Implants
The era is increasingly demanding for customized solutions, including the development of 3D models for surgeons to practice and establish patient-specific surgical guides or implants.
Spurring Fourth-Generation MIS
Innovative methods, such as extra-articular transverse osteotomies, are allowing multi-directional correction with stable fixation.
Shifting Towards Robotic Assistance
The globe is immensely stepping into the promotion of robotic-assisted surgery, which enables more intricate movements with raised precision, potentially resulting in minimal complications.
| Key Elements | Scope |
| Market Size in 2026 | USD 517.6 Million |
| Projected Market Size in 2035 | USD 855.36 Million |
| CAGR (2026 - 2035) | 5.74% |
| Leading Region | North America by 45% |
| Historical Data | 2020 - 2023 |
| Base Year | 2025 |
| Forecast Period | 2026 - 2035 |
| Measurable Values | USD Millions/Units/Volume |
| Market Segmentation | By Product Type, By Patient Type, By Surgery Type, By End-User, By Region |
| Top Key Players | Stryker Corporation, Johnson & Johnson Services, Inc., Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Paragon 28, Inc., CONMED Corporation, Enovis Corporation, Medartis AG, Orthofix Medical Inc, Exactech, Inc. |
| Segments | Shares % |
| Correction Systems | 60% |
| Implants & Accessories | 40% |
Which Product Type Led the Bunion Surgery Market in 2025?
In 2025, the correction systems segment captured the dominating share of 60% of the market. It has significant advantages, like highlighting the root cause of the deformity, enhanced stability, quicker recovery, and a reduced chance of the bunion returning. Globally rising adoption of Lapiplasty procedures, which leverages specialized, single or dual low-profile titanium plates for accurate rotation and stabilization of the first metatarsal bone into its correct anatomical position. The latest advanced Percuplasty Percutaneous 3D bunions correction system facilitates precise 3D correction with cosmetically appealing incisions.
Implants & Accessories
Moreover, the implants & accessories segment is anticipated to expand fastest. Instead of traditional implants, surgeons are encouraging "smart" implants coupled with sensors to transmit real-time data on mechanical stress, movement, and healing growth. The market is transforming utilization of biomaterials, especially magnesium alloys, which are naturally dissolvable in the body after the bone has healed, and also combats the need for a second hardware removal surgery.
| Segments | Shares % |
| Adults patients | 70% |
| Pediatric patients | 30% |
How did the Adults Patients Segment Dominate the Bunion Surgery Market in 2025?
Primarily, the adults patients segment held the biggest share of 70% of the market in 2025. Specifically, 18-65+ aged people are suffering from bunions, which is fueled by diverse lifestyle factors, sports injuries, joint degeneration and age-related conditions, including arthritis. However, they are broadly demanding advanced minimally invasive techniques, sophisticated fixation devices, and the use of robotic-assisted technology.
Pediatric Patients
The pediatric patients segment will expand notably. The worldwide increase in congenital/developmental concerns, sports injuries, improper footwear, and rising awareness are propelling the growth of bunion surgery. A key solution comprises a transverse extra-articular metatarsal osteotomy using two cannulated screws united with an Akin osteotomy. Whereas, DePuy Synthes unveiled the TriLEAP Lower Extremity Anatomic Plating System for bunionectomies and osteotomies in complex pediatric foot fractures and deformities.
| Segments | Shares % |
| Traditional Surgery | 60% |
| Minimally Invasive Surgery | 40% |
Which Surgery Type Led the Bunion Surgery Market in 2025?
In 2025, the traditional surgery segment registered dominance in the market by 60% share. This surgical type is well-developed and widely successful for correcting severe or complex bunion deformities where MIS might not satisfy. This often includes an osteotomy, which needs a larger incision (inches long) to access the joint, discard the bony prominence, i.e. exostectomy, and reposition the misaligned bones.
Minimally Invasive Surgery
Whereas the minimally invasive surgery segment is predicted to witness rapid expansion. Modernized MIS emphasises raising precision, boosting recovery, and lowering recurrence rates through sophisticated instrumentation, 3D planning technologies, and refined surgical methods. The leading firms are putting efforts into progressing procedure-specific hardware and tools, like the PROstep MIS Lapidus by Stryker, and specialized burrs, which accelerate the safety and efficiency of minimally invasive procedures.
| Segments | Shares % |
| Hospitals | 55% |
| Orthopaedic Clinics | 30% |
| Ambulatory Surgical Centers | 10% |
| Others | 5% |
Why did the Hospitals Segment Lead the Market in 2025?
The hospitals segment captured the largest share of the bunion surgery market by 55% share in 2025. These are prominent end-users, which provide skilled surgeons and the availability of different techniques, such as exostectomy, osteotomy, and arthrodesis for correction. Alongside, they are focusing on improvements in post-operative care, with the adoption of multimodal pain management and strengthened rehabilitation programs that support early mobilization.
Orthopaedic Clinics
In the future, the orthopaedic clinics segment is anticipated to expand at a rapid CAGR. A rise in the burden of deformities, demand for better outcomes, and broadening awareness are assisting the expansion of these clinics. Additionally, clinics are fostering the use of next-gen implants, surgical tools, and AI-driven strategies. Also, they are shifting towards a single, dual-zone neutral pitch screw construct, which offers extensive stability for healing, with a streamlined procedure.
North America held the largest share of 45% of the market in 2025, due to the ongoing breakthrough in surgical techniques, such as MIS, robust implants, and escalating instances of related issues, especially arthritis. Furthermore, the region is embedding novel "same-day" protocols that often enable patients to initiate gentle range-of-motion exercises within days and return to light activity in 4–6 weeks.
U.S. Market Trends
However, the U.S. was a major contributor to the market, as it is promoting cloud-driven platforms and pre-operative software, for example, Johnson & Johnson's Virtue Guide system, which is employed in digital planning of surgeries and monitoring post-operative progress, ultimately allowing tailored care and raising patient involvement.
Asia Pacific is estimated to expand fastest in the bunion surgery market by 15% share, as the region is experiencing the expedited expansion of medical infrastructure, accelerating healthcare spending, primarily in Japan, South Korea, and Southeast Asia. Besides this, APAC is widening the use of AI in pre-operative evaluation and surgical planning. Whereas, AI-enabled solutions are exploring the analysis of patient-specific data from imaging to implement proper surgical techniques.
Japan Market Trends
Japan is predicted to expand at a rapid CAGR with substantial advancements in the surgical area. They have robust healthcare facilities, such as Foot Clinic Omotesando, The Clinical and Research Institute for Foot & Ankle Surgery, and Marugame Orthopedic Clinic. They are executing diverse approaches, particularly innovation in advanced, cutting-edge minimally invasive orthopedic treatments.
The European bunion surgery market is growing share of 30% due to an aging population, rising prevalence of hallux valgus, and advancements in surgical techniques. Minimally invasive surgery (MIS) is gaining popularity for its smaller incisions, reduced tissue damage, less postoperative pain, and faster recovery. The shift towards outpatient procedures is accelerating this trend. As the population ages, orthopedic issues like hallux valgus increase, driving demand for surgery. Additionally, factors like rheumatoid arthritis, obesity, and poor footwear choices contribute to more foot deformities. New implant designs and robotic systems enhance surgical outcomes and reduce recurrence rates.
Germany Market Trends
Germany dominates the European market, generating the highest revenue due to its robust healthcare system, high prevalence of foot disorders, and a thriving medical tourism sector. The aging population and common foot deformities like hallux valgus increase the demand for surgical options. Renowned for its advanced medical facilities and high-quality orthopedic care, Germany has highly skilled, board-certified surgeons specializing in orthopedic surgeries. The country is also a hub for orthopedic innovation, offering specialized procedures such as Scarf osteotomy and minimally invasive Chevron-Akin techniques. Furthermore, Germany hosts numerous research institutions and prioritizes advanced implants and robotic-assisted technology, particularly in the rapidly growing implants and accessories sector, driven by innovations in titanium implants and corrective technologies.
South America is expanding in the bunion surgery market due to improved healthcare infrastructure, increased patient awareness of advanced treatments, and a rising demand for minimally invasive procedures (MIS). Post-pandemic, the region is seeing a surge in technology investments, a higher incidence of foot problems, and a growing need for specialized orthopedic care. The pandemic highlighted healthcare gaps, prompting a focus on enhancing hospital facilities, particularly in orthopedics. The popularity of advanced minimally invasive procedures, like endoscopic and robotic techniques, is driving market growth due to shorter hospital stays and better outcomes. Better access to healthcare and more specialized orthopedic centers, along with various surgical and non-invasive treatment options, are supporting this trend.
Brazil Market Trends
Brazil has established itself as a leader in the Latin American market, offering high-quality orthopedic care at lower prices than in North America or Europe. The country's prominence in minimally invasive surgical (MIS) techniques is driven by several key factors. Globally, Brazil is recognized for its expertise in specialized surgeries, particularly orthopedics, with internationally accredited hospitals featuring advanced technology in major cities like São Paulo and Rio de Janeiro. Brazil excels in percutaneous surgery for hallux valgus correction, with MIS techniques that involve smaller incisions, leading to quicker recovery, reduced postoperative pain, and earlier weight-bearing, making them attractive to patients. The Brazilian orthopedic implant market is supported by a strong domestic manufacturing sector, including companies like MDT, GMReis, and Baumer, which produce advanced, cost-effective, locally sourced implants.
R&D
Clinical Trials & Regulatory Approvals
Patient Support & Services
| Company | Description |
| Stryker Corporation | They highly specialise in PROstep Minimally Invasive Surgery (MIS). |
| Johnson & Johnson Services, Inc | Its prominent offerings include the VIRTUGUIDE System, MINIBUNION 3D System, etc. |
| Zimmer Biomet Holdings, Inc. | This explores many products through its foot and ankle portfolio. |
| Smith & Nephew plc | A firm mainly offers plating systems for bone fixation and bioinductive implants for soft tissue repair. |
| Paragon 28, Inc | It has unveiled the PRECISION MIS Bunion System. |
| CONMED Corporation | It facilitates different products through its CoLink & NeoSpan product families. |
| Enovis Corporation | This emphasizes minimally invasive surgery (MIS) techniques and products for traditional open procedures and post-operative care. |
| Medartis AG | It offers various high-precision implant systems for bunion surgery. |
| Orthofix Medical Inc. | This specializes in implants and fixation systems through its vast portfolio of limb reconstruction and orthopedic solutions. |
| Exactech, Inc | Its offering encompasses its comprehensive EPIC Extremity Reconstruction System. |
By Product Type
By Patient Type
By Surgery Type
By End-User
By Region
Reviewed By
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.
Learn more about Aditi ShivarkarApril 2026
April 2026
April 2026
April 2026
sales@towardshealthcare.com
+1 804-441-9344
